Lectins are proteins and glycoproteins derived from a wide variety of biological sources. Their various properties depend on their ability to bind specifically to certain saccharide residues. They are thus able to react with the glycosylated components of cells and have been extensively used in the study of both normal and neoplastic tissues including breast'4 and large intestine."7 Studies of lectin binding in human endometrium have, however, been rather limited. 8 Various metabolic changes occur in the endometrium during the normal menstrual cycle, and changes in the activities of enzymes such as nonspecific esterases, lactate dehydrogenase, and alkaline phosphatase have been recorded. 9 '°Glycogen is synthesised at certain stages of the cycle and changes in glycoprotein production also occur. ' Standard techniques of carbohydrate histochemistry such as periodic acid Schiff (PAS) and alcian blue have been applied to human endometrium." The use of lectins, however, permits more specific identification of changes in tissue carbohydrates which occur during the menstrual cycle.
The glycosylated components of cells and particularly of cell membranes have been implicated in several cellular reactions such as cell-cell interaction, Accepted for publication September 1988 cell-substrate interaction, and hormone binding. '2-'4 Changes in such properties could be important in the development of neoplasia and several studies have been performed comparing the glycosubstances of neoplastic cells with their normal counterparts. '516 Lectins for example, peanut and wheat germ agglutinins have been previously used to detect changes in the carbohydrate composition of malignant cells both in tissue sections'6 and in cell suspensions. '7 8 Only one previous study of lectin binding to human endometrial carcinoma, however, has been undertaken.'
The purpose of this study was to determine the pattern of lectin binding in endometrium during different phases of the menstrual cycle, to assess the reactivity of endometrial carcinomas, and to compare these to those of non-malignant tissues. The seven lectins used have a range of specificities encompassing galactose and N-acetyl-D-galactosamine, N-acetyl-Dglucosamine, sialic acid, fucose and mannose.
Material and methods
Fifty cases each of proliferative endometrium, secretory endometrium, and endometrial adenocarcinoma were retrieved from the histopathology files of this hospital. All specimens had been fixed in 10% Previous digestion of tissue sections with trypsin, while slightly enhancing the intensity of staining in a small number of cases, had no effect on the distribution of reactivity with any of the lectins used. Staining with all the lectins except Lens culinaris (LCA) was inhibited by incubation with the appropriate inhibitory sugars as shown in table 1. As LCA did not stain any of the cases studied the effect of its inhibitor could not be assessed. The binding of Triticum vulgare (WGA), Ulex europaeus (UEA), Dolichos biflorus (DBA) and LCA was unaffected by pretreatment with neuraminidase. 23 especially in dimeric or trimeric form but will also bind to sialic (N-acetylneuraminic) acid.24 As neuraminidase preferentially cleaves terminal sialic acid residues2' and it did not affect WGA binding, the lectin may be detecting N-acetyl-D-glucosamine in the endometrium. This cannot be stated with certainty, however, as we have no definitive proof that sialic acid is removed.
Despite apparent similarities lectins with affinity for D-galactosyl and N-acetyl-D-galactosaminyl residues produce varying results. PNA has a strong affinity for galactosyl-#-(1-3)-N-acetyl-D-galactosaminyl residues.2526 The staining of the luminal surfaces of Endometrial lectin binding proliferative glands suggests that this disaccharide is present. The loss of reactivity in the secretory phase and its restoration by neuraminidase treatment indicates that sialylation of the PNA binding sites has occurred. An increase in sialomucins in late secretory endometrium has previously been shown histochemically.36 This could be the result ofincreased sialyl transferase activity, and the timing of this change suggests a possible role for progesterone in its mediation. Serum progesterone activities rise during the secretory phase and there is an increase in endometrial progesterone receptors at this time. 37 The binding of DBA also showed cyclical variations, although these were less pronounced than those seen with PNA. Terminal N-acetyl-D-galactosamine27 was detected at the luminal surface only in secretory endometrium. The distribution of this residue may, therefore, be controlled by a glycosyltransferase under hormonal influence.
MPA and BSA-1 showed consistent binding patterns throughout the menstrual cycle. MPA has affinity for a-D-galactose and N-acetyl-D-galactosamine2829 but will also bind to galactose-#-(1-3)-N- Staining was unaffected by neuraminidase, thus indicating the widespread presence of N-acetyl-Dglucosamine at the surface of neoplastic lumina and to a lesser extent in tumour cell cytoplasm.
After treatment with neuraminidase all carcinomas exhibited abundant staining with PNA, regardless of the extent of reactivity without enzymatic manipulation. Those tumours showing scanty staining without neuraminidase digestion may be likened to secretory endometrium, and possibly the differential sialylation of PNA binding sites may depend on hormones. Progesterone receptors have been detected in some endometrial adenocarcinomas.3839 The presence of such receptors could determine the extent of sialylation of PNA binding sites and might predict the response to progesterone treatment. As in normal endometrium the synthesis of the progesterone receptors may be influenced by oestrogen37 which has also been implicated in the pathogenesis of endometrial carcinoma. Another possible explanation of the variable sialylation of PNA binding sites is that some of the patients may have been receiving therapeutic progestogens. Clearly, further study of the association between PNA binding, steroid hormone concentrations, and tumour receptor state would be of value. Similar studies in breast carcinoma have found an association between PNA binding and oestrogen receptor content. 40 Half of the cases of carcinoma showed DBA reactivity. The staining was heterogeneous and was not related to ABO blood group. In nine cases variable staining of glandular luminal surfaces and secretions was noted similar to the staining pattern observed in some cases of secretory endometrium. These findings, like those seen with PNA, may be the result of differences in hormonal environment or Lack of staining of cyclical endometrium and endometrial carcinomas by LCA indicates the absence of detectable bi-antennate and tri-antennate N-linked glycans containing mannosyl residues. More than one commercial batch of the lectin was used, and other tissues comprising part of a different project were reactive. It therefore seems that the lack of staining by LCA in endometrial tissues was due to a lack of binding sites and not to any technical problems.
The results of this study show that HRP conjugated lectins can be used to show the presence of glycosylated components of both normal and neoplastic human endometrium in formalin fixed, paraffin wax processed tissues. Changes in these components can be detected at certain stages of the menstrual cycle and in neoplasia. Comparisons of binding patterns in normal proliferative and secretory endometrium with endometrial carcinomas, however, should be made with care as, by definition, the former come from premenopausal women and many of the latter are from postmenopausal women.
One avenue not explored in this study is the possible clinical importance of the extent and distribution of lectin staining in endometrial carcinomas in relation to tumour behaviour and prognosis. This could form the basis for a further study, as could a detailed study of lectin binding in atypical endometrial hyperplasia.
